60 Degrees Pharmaceuticals- Warrants (16/05/2028) Overview
Valuation check: SXTPW's P/E ratio is 0.0, below the sector sector average of 47.3.
Get informed when a big investor buys or sells
+ Follow0.00
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for SXTPW is 0.0. That is below the sector sector average of 47.3. Investors often review this figure alongside 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, SXTPW currently prints 0.0 for P/E ratio, while the sector average sits near 47.3. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s growth, margins, and balance sheet.
A P/E ratio of 0.0 for 60 Degrees Pharmaceuticals- Warrants (16/05/2028) is not 'good' or 'bad' on its own. Compare it with the peer average (47.3) and with SXTPW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting SXTPW's P/E ratio (0.0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
